Skip to main content
Log in

Usually available clinical and laboratory data are insufficient for a valid medication review: A crossover study

  • Published:
The journal of nutrition, health & aging

Abstract

Objectives

To establish the quality of medication reviews performed by nursing home physicians, general practitioners and pharmacists.

Design and setting

15 Pharmacists, 13 general practitioners and 18 nursing home physicians performed a medication review for three cases (A, B and C), at three evaluation moments. First, they received the medication list. Secondly, they also received laboratory results and reason for admission and finally, we added medical history. Remarks were divided into 6 categories, i.e. indication without medication, medication without indication, contraindications/ interactions, dosage problems, double medication and wrong medication. Remarks were compared to the remarks made by our expert panel and scored according to our grading model as appropriate (0 to +3) or missed or potentially harmful (-1). For each medication error category, the percentage of participants who made this error was computed.

Results

After the first evaluation moment, the overall estimated mean percentage score was -1.7% for case A, 3.9% for case B, and 8.7% for case C. After the second review, this score was 15.0% for case A, 19.8% for case B, and 22.2% for case C. This further increased to 30.0% for case A, 36.7% for case B and 44% for case C at the final evaluation. The absence of medication where there was an indication (indication without medication) was frequently missed and did not improve after adding the extra information regarding laboratory results, reason for admission and finally medical history.

Conclusion

Increasing clinical information helps physicians and pharmacists to improve their medication reviews, however, additional information was still related with a high margin of error. Detection of certain errors becomes easier with additional information, whereas other errors remain undetected. To achieve a high standard of medication review, we have to change the way medication reviews should be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. McKhann GM et al. The diagnosis of dementia due to Alzheimer’s disease: 1. Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes 2011;9: 95

    Article  Google Scholar 

  2. Fortin M, Lapointe L, Hudon C, Vanasse A. Multimorbidity is common to family practice: is it commonly researched? Can Fam Physician 2005;51: 244–245

    PubMed  Google Scholar 

  3. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. Jama 2002;287: 337–344

    Article  PubMed  Google Scholar 

  4. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci 2012;67: 698–704

    Article  PubMed  Google Scholar 

  5. Bronskill SE, Gill SS, Paterson JM, Bell CM, Anderson GM, Rochon PA. Exploring variation in rates of polypharmacy across long term care homes. J Am Med Dir Assoc 2012;13: 309, e315–321

    Google Scholar 

  6. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001;49: 200–209

    Article  PubMed  CAS  Google Scholar 

  7. Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging 2005;22: 559–569

    Article  PubMed  Google Scholar 

  8. Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008;168: 1890–1896

    PubMed  Google Scholar 

  9. Mannesse CK, Derkx FH, de Ridder MA, Man Veld AJ, van der Cammen TJ. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000;29: 35–39

    Article  PubMed  CAS  Google Scholar 

  10. Paul A.F. Jansen JRBJB. Clinical Pharmacology in old persons. Scientifica 2012

    Google Scholar 

  11. de Wit HA, Mestres Gonzalvo C, Hurkens KP, Mulder WJ, Janknegt R, Verhey FR, Schols JM, van der Kuy PH. Development of a computer system to support medication reviews in nursing homes. International journal of clinical pharmacy 2013;35: 668–672

    Article  PubMed  Google Scholar 

  12. Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med 2003;348: 2526–2534

    Article  PubMed  Google Scholar 

  13. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Archives of internal medicine 2006;166: 955–964

    Article  PubMed  Google Scholar 

  14. Schnipper JL, Rothschild JM. Improving medication safety. Lancet, 2012

    Google Scholar 

  15. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database 2012;Syst Rev 5: CD008165

  16. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007;370: 173–184

    Article  PubMed  Google Scholar 

  17. Ministery of Health. Medicatieveiligheid voor kwetsbare groepen in de langdurige zorg en zorg thuis onvoldoende. Rapport Inspectie voor de Gezondheidszorg. Ministerie van Volksgezondheid, Welzijn en Sport, 2010.

    Google Scholar 

  18. Corp I (Released 2013) IBM SPSS Statistics for Windows, 2013.

  19. Drenth-van Maanen AC, van Marum RJ, Knol W, van der Linden CM, Jansen PA. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging 2009;26: 687–701

    Article  PubMed  Google Scholar 

  20. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing. A randomized controlled trial. Med Care 1992;30: 646–658

    Article  PubMed  CAS  Google Scholar 

  21. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, Wilson DA, McCarthy ST, Brooks GE, de Looze FJ et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001;51: 257–265

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Hellstrom LM, Bondesson A, Hoglund P, Midlov P, Holmdahl L, Rickhag E, Eriksson T. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol 2011;67: 741–752

    Article  PubMed  Google Scholar 

  23. Allard J, Hebert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. Cmaj 164: 2001;1291–1296

    PubMed  CAS  PubMed Central  Google Scholar 

  24. Furniss L, Burns A, Craig SK, Scobie S, Cooke J, Faragher B. Effects of a pharmacist’s medication review in nursing homes. Randomised controlled trial. Br J Psychiatry 2000;176: 563–567

    Article  PubMed  CAS  Google Scholar 

  25. Tjia J, Velten SJ, Parsons C, Valluri S, Briesacher BA. Studies to reduce unnecessary medication use in frail older adults: a systematic review. Drugs Aging 2013;30: 285–307

    Article  PubMed  Google Scholar 

  26. Olsson IN, Curman B, Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf 2010;19: 150–157

    Article  PubMed  Google Scholar 

  27. Gallagher PF, O’Connor MN, O’Mahony D Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther 2010;89: 845–854

    Article  Google Scholar 

  28. Garfinkel D, Mangin D Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med 2010;170: 1648–1654

    Article  PubMed  Google Scholar 

  29. Lang PO, Vogt-Ferrier N, Hasso Y, Le Saint L, Drame M, Zekry D, Huber P, Chamot C, Gattelet P, Prudent M et al. Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: interventional study in 150 acutely ill elderly patients with mental and somatic comorbid conditions. J Am Med Dir Assoc 2012;13: 406, e401–407

    Google Scholar 

  30. Barry PJ, Gallagher P, Ryan C, O’Mahony D. START (screening tool to alert doctors to the right treatment)—an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007;36: 632–638

    Article  PubMed  CAS  Google Scholar 

  31. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. Jama 1999;282: 113–115

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kim P.G.M. Hurkens.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hurkens, K., Mestres-Gonzalvo, C., De Wit, H. et al. Usually available clinical and laboratory data are insufficient for a valid medication review: A crossover study. J Nutr Health Aging 20, 71–76 (2016). https://doi.org/10.1007/s12603-016-0678-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-016-0678-1

Keywords

Navigation